Data / Medical devices / United States / Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.: FDA-registered device maker in E Walpole, MA, United States, 89 510(k) clearances and 15 PMA approvals
Siemens Healthcare Diagnostics Inc. is registered with the FDA (registration 1219913) in E Walpole, MA, United States. It lists 96 device types. The FDA files 89 510(k) clearances and 15 PMA approvals under its listings, the newest dated August 10, 2026. 74 recall events name it as the recalling firm. Registered through 2027. FDA data exported November 3, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 1219913
- Address
- 333 Coney Street, E Walpole, MA, United States, 02032
- Owner or operator
- SIEMENS HEALTHCARE DIAGNOSTICS INC. (9096044)
- Roles
- Manufacturer, Manufacturer for export, Repackager or relabeler, Specification developer
- First device listed
- April 18, 1995
- Registered through
- 2027
- Brand names listed
- 600 Series Blood Gas, ADVIA, ADVIA CENTAUR TOXOPLASM, ADVIA Centaur, ADVIA Centaur AFP, ADVIA Centaur AMH Master Curve Material (AMH MCM), ADVIA Centaur AMH Quality Control (AMH QC), ADVIA Centaur Acid and Base Reagents and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| August 10, 2026 | K253528 | Atellica IM CA 19-9 II | NIG | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| January 5, 2026 | K251630 | Atellica IM Total PSA II (tPSAII) | LTJ | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| December 4, 2025 | K250816 | ADVIA Centaur Anti-Thyroglobulin II (aTgII) | JNL | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| October 17, 2025 | K250250 | ADVIA Centaur Anti-Thyroid Peroxidase II | JZO | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| June 20, 2025 | K242981 | Atellica IM Thyroglobulin (Tg) | MSW | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| July 25, 2024 | K241165 | Atellica® IM High-Sensitivity Troponin I (TnIH) | MMI | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| April 4, 2024 | K233050 | ADVIA Centaur® TSH3-Ultra II (TSH3ULII) | JLW | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| September 24, 2023 | K220265 | ADVIA Centaur® NT-proBNPII (PBNPII) | NBC | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| July 13, 2023 | K222116 | Atellica® CI Analyzer, Atellica® IMThyroid Stimulating Hormone 3-Ultra (TSH3-UL), Atellica® CH Albumin BCP (AlbP) | JLW | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| June 2, 2023 | K221801 | ADVIA Centaur® Anti-Müllerian Hormone (AMH) | PQO | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| August 20, 2021 | DEN190056 | ADVIA Centaur Enhanced Liver Fibrosis (ELF) | QQB | Unknown | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| July 13, 2021 | K200210 | ADVIA Centaur® Total hCG assay | DHA | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| April 13, 2020 | K200215 | ADVIA Centaur CEA Assay | DHX | Substantially Equivalent | Siemens Healthcare Disgnostics, Inc. | accessdata.fda.gov |
| April 6, 2020 | K200199 | ADVIA Centaur CA 125II | LTK | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| November 22, 2019 | K192777 | ADVIA Centaur CA 15-3 assay | MOI | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| October 30, 2019 | K192790 | Atellica IM Total hCG (ThCG) | DHA | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| August 28, 2019 | K191533 | ADVIA Centaur Testosterone II (TSTII), ADVIA Centaur SHBG | CDZ | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| July 17, 2019 | K191578 | ADVIA Centaur Zika test, ADVIA Centaur Zika Ab (100 tests), ADVIA Centaur Zika IgM (50 tests), ADVIA Centaur Zika Ab Quality Control, ADVIA Centaur Zika IgM Quality Control | QFO | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| July 30, 2018 | K181213 | ADVIA Centaur CMV IgG and ADVIA Centaur CMV IgG Quality Control | LFZ | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| July 16, 2018 | K181002 | Atellica IM BRAHMS Procalcitonin (PCT) | PMT | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| July 12, 2018 | K171274 | ADVIA Centaur High-Sensitivity Troponin I (TNIH) | MMI | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| April 12, 2018 | K172201 | Atellica IM Folate Assay | CGN | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| August 31, 2017 | K171642 | Atellica IM Ferritin Assay | DBF | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| May 23, 2017 | K163658 | ADVIA Centaur Intact Parathyroid Hormone (PTH) Assay | CEW | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| June 29, 2016 | K151986 | ADVA Centaur Testosterone II (TSTII), ADVA Centaur Testosterone II (TSTII) Master Curve Material, ADVIA Centaur SHBG, ADVIA Centaur SHBG Calibrator, ADVIA Centaur SHBG Master Curve Material | CDZ | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| May 1, 2015 | K150403 | ADVIA Centaur TSH3-Ultra | JLW | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| January 27, 2015 | K143680 | ADVIA Centaur IgE Master Curve Material | JJX | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| December 23, 2014 | K143376 | ADIVA Centaur Progesterone Master Curve Material (MCM), ADIVA Centaur Ferritin Master Curve Material | JJX | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| December 5, 2014 | K143194 | ADIVA Centaur Prolactin Master Curve Material (MCM), ADIVA Centaur Cortisol Master Curve Material (MCM) | JJX | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| July 24, 2014 | K133156 | ADVIA CENTAUR VITAMIN D TOTAL (VITD) ASSAY;ADVIA CENTAUR VITD TOTAL CALIBRATORS,QUALITY CONTROL & MASTER CONTROL MATERIA | MRG | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| March 31, 2014 | K140505 | ADVIA CENTAUR VITAMIN B12 MASTER CURVE MATERIAL, TOTAL HCG MASTER CURVE MATERIAL, AND TESTOSTERONE MASTER CURVE MATERIAL | JJX | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| March 10, 2014 | K140267 | ADVIA CENTAUR TNI-ULTRA MASTER CURVE MATERIAL (MCM), ADVIA CENTAUR DIGOXIN MASTER CURVE MATERIAL (MCM) | JJX | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| February 5, 2014 | K133601 | ADVIA CENTAUR INTACT PARATHYROID HORMONE (IPTH) ASSAY | CEW | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| September 13, 2013 | K132249 | ADVIA CENTAUR FT4, ADVIA CENTAUR T4 | CEC | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| March 21, 2013 | K121981 | ADVIA CENTAUR INACT PARATHYROID HORMONE (IPTH) ASSAY | CEW | Substantially Equivalent | Siemens Healthcare Diagnostics | accessdata.fda.gov |
| January 20, 2012 | K112343 | TREPONEMA PALLIDUM TREPONEMAL TEST REAGENTS; QUALITY CONTROL MATERIALS | LIP | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| October 14, 2011 | K110586 | ADVIA CENTAUR VITAMIN D TOTAL ASSAY | MRG | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| June 2, 2011 | K103548 | ADVIA CENTAUR CALIBARATOR 80 MODEL 10492491 | JIT | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. | accessdata.fda.gov |
| November 23, 2010 | K102904 | ENHANCED ESTRADIOL (EE2) MASTER CURVE MATERIAL | JJX | Substantially Equivalent | Siemens Healthcare Diagnostics | accessdata.fda.gov |
| May 13, 2010 | K100433 | IMMULITE 2000 CMV IGM, IMMULITE CMV IGM CONTROLS, AND IMMULITE 200 CMV IGM ADJUSTOR MODEL L2KCM2, L2KCM6, LCMC1, LCMC2, | LKQ | Substantially Equivalent | Siemens Healthcare Diagnostics | accessdata.fda.gov |
| March 19, 2010 | K100293 | ADVIA CENTAUR CALIBRATOR 30, MODELS 10379811/10379810 | JIT | Substantially Equivalent | Siemens Heatlhcare Diagnostics, Inc. | accessdata.fda.gov |
| November 20, 2009 | K092993 | ADVIA CENTAUR CYCLOSPORINE MASTER CURVE MATERIAL | JJX | Substantially Equivalent | Siemens Healthcare Diagnostics | accessdata.fda.gov |
| August 14, 2009 | K091123 | ADVIA CENTAUR DHEAS MASTER CURVE MATERIALS | JJX | Substantially Equivalent | Siemens Healthcare Diagnostics | accessdata.fda.gov |
| May 8, 2009 | K083844 | ADVIA CENTAUR TSH3-ULTRA METHOD | JLW | Substantially Equivalent | Siemens Healthcare Diagnostics | accessdata.fda.gov |
| September 11, 2008 | K071455 | ADVIA CENTAUR CYCLOSPORINE ASSAY AND CALIBRATOR | MKW | Substantially Equivalent | Siemens Medical Solutions Diagnostics | accessdata.fda.gov |
| July 2, 2004 | K041133 | MODIFICATION TO BAYER ADVIA CENTAUR AUTOMATED CHEMILUMINESCENCE ANALYZER | CDD | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| June 14, 2004 | K040425 | ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS | NBC | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| December 17, 2003 | K031560 | BAYER RAPIDLAB 1200 SYSTEM | CHL | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| September 9, 2003 | K032525 | BAYER ADVIA CENTAUR AUTOMATED CHEMILUMINESCENCE ANALYZER | NBC | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| June 24, 2003 | K031393 | BAYER ADVIA CENTAUR CA 19-9 ASSAY | NIG | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| June 23, 2003 | K031038 | ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAY | NBC | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| January 30, 2003 | K024017 | BAYER ADVIA CENTAUR HER-2/NEU ASSAY | NCW | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| July 24, 2002 | K020828 | CA 125 ASSAY FOR THE ADVIA CENTAUR SYSTEM | LTK | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| March 27, 2002 | K020806 | ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY | LOJ | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| March 15, 2002 | K020217 | ACS:180 AND ADVIA CENTAUR IPTH IMMUNOASSAY | JJX | Substantially Equivalent | Bayer Diagnostics Corp. | accessdata.fda.gov |
| February 28, 2002 | K012357 | CA 15-3 ASSAY FOR THE ADVIA CENTAUR SYSTEM | MOI | Substantially Equivalent | Bayer Diagnostics Corp. | accessdata.fda.gov |
| December 27, 2001 | K012183 | BAYER DIAGNOSTICS ADVIA CENTAUR TOXOPLASMA IGG ASSAY | LGD | Substantially Equivalent | Bayer Diagnostics Corp. | accessdata.fda.gov |
| December 18, 2001 | K013406 | ADVIA CENTAUR HOMOCYSTEINE ASSAY | LPS | Substantially Equivalent | Bayer Diagnostics Corp. | accessdata.fda.gov |
| October 22, 2001 | K012777 | ACS: 180 AND ADVIA CENTAUR ANTI-THYROGLOBULIN IMMUNOASSAYS | JZO | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| August 20, 2001 | K010755 | BAYER DIAGNOSTICS ADVIA CENTAUR TOXOPLASMA IGM ASSAY | LGD | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| July 5, 2001 | K010668 | BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAY | LFX | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| July 2, 2001 | K011303 | RANDOX PHENOBARBITAL | DLZ | Substantially Equivalent | Randox Laboratories, Ltd. | accessdata.fda.gov |
| April 13, 2001 | K003412 | ADVIA CENTAUR RUBELLA IGG ASSAY | LFX | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| February 5, 2001 | K010050 | ADVIA CENTAUR AND ACS: 180 FOLATE IMMUNOASSAY | CGN | Substantially Equivalent | Bayer Diagnostics Corp. | accessdata.fda.gov |
| December 19, 2000 | K002738 | BAYER RAPIDPOINT 400 SYSTEM | CHL | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| December 5, 2000 | K003291 | BAYER DIAGNOSTICS ACS:180 AND ADVIA CENTAUR ANTI-TPO ASSAY | JZO | Substantially Equivalent | Bayer Diagnostics Corp. | accessdata.fda.gov |
| December 16, 1999 | K993571 | BAYER DIAGNOSTICS ACS:180 VB12, BAYER DIAGNOSTICS ADVIA CENTAUE VB12 | CDD | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| December 6, 1999 | K993309 | BAYER DIAGNOSTICS ACS:180 AND ADVIA CENTAUR TROPONIN I ASSAY | MMI | Substantially Equivalent | Bayer Corp. | accessdata.fda.gov |
| November 12, 1999 | K993254 | IMMULITE 2000 FOLIC ACID, MODEL L2KF02, L2KF06 | CGN | Substantially Equivalent | Diagnostic Products Corp. | accessdata.fda.gov |
| August 5, 1999 | K992157 | CHIRON DIAGNOSTICS ACS: 180 FERRITIN ASSAY | DBF | Substantially Equivalent | Chiron Diagnostics Corp. | accessdata.fda.gov |
| June 18, 1999 | K991692 | CHIRON DIAGNOSTICS ACS: 180 FT3 | CDP | Substantially Equivalent | Chiron Diagnostics Corp. | accessdata.fda.gov |
| October 15, 1998 | K982680 | CHIRON DIAGNOSTICS CORPORATION ACS: CENTAUR BR IMMUNOASSAY | MOI | Substantially Equivalent | Chiron Diagnostics Corp. | accessdata.fda.gov |
| August 12, 1998 | K981478 | ACS:CENTAUR CEA | DHX | Substantially Equivalent | Chiron Diagnostics Corp. | accessdata.fda.gov |
| December 8, 1997 | K974325 | CHIRON DIAGNOSTICS ACS:180 MYOGLOBIN | DDR | Substantially Equivalent | Chiron Diagnostics Corp. | accessdata.fda.gov |
| March 24, 1997 | K970539 | CHIRON DIAGNOSTICS ACS:180TU P | KHQ | Substantially Equivalent | Chiron Diagnostics Corp. | accessdata.fda.gov |
| November 5, 1996 | K962559 | ACS CORTISOL IMMUNOASSAY | JFT | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| June 21, 1996 | K962126 | ACS CKMB II IMMUNOASSAY | JHS | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| June 21, 1996 | K962041 | ACS LH2 IMMUNOASSAY | CEP | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| June 17, 1996 | K961510 | ACS FRT4 IMMUNOASSAY | JJX | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| March 11, 1996 | K955873 | ACS PHENYTOIN ASSAY | LGR | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| August 2, 1993 | K932955 | CIBA CORNING ACS PROGESTERONE IMMUNOASSAY | JLS | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| March 19, 1993 | K925277 | CIBA CORNING ACS HCG IMMUNOASSAY | JHI | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| April 8, 1992 | K920372 | ACS TOTAL IGE IMMUNOASSAY | DGC | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| October 25, 1991 | K913646 | CIBA CORNING ACS T3 IMMUNOASSAY | CDD | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| April 3, 1991 | K911121 | CIBA CORNING ACS CKMB IMMUNOASSAY | JHX | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| February 4, 1991 | K910198 | CIBA CORNING ACS LH IMMUNOASSAY | CEP | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| January 15, 1991 | K905532 | CIBA CORNING ACS T4 IMMUNOASSAY | CDX | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| November 20, 1990 | K904649 | CIBA CORNING ACS FSH IMMUNOASSAY | CGJ | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
| November 7, 1990 | K904714 | CIBA CORNING ACS PROLACTIN IMMUNOASSAY | CFT | Substantially Equivalent | Ciba Corning Diagnostics Corp. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| May 11, 2026 | P250026 | Atellica IM free PSA II (fPSAII) | MTG | 0 | May 11, 2026 | accessdata.fda.gov |
| December 3, 2025 | P240021 | Atellica IM Total PSA II (tPSAII) | MTF | 1 | August 26, 2026 | accessdata.fda.gov |
| July 27, 2022 | P210019 | ADVIA Centaur Anti-HBc Total (HBcT2) and Atellica IM Anti-HBc Total (HBcT2) | SEI | 4 | October 17, 2025 | accessdata.fda.gov |
| May 16, 2014 | P110041 | ADVIA CENTAUR HBSAGII | LOM | 17 | October 17, 2025 | accessdata.fda.gov |
| January 20, 2012 | P100039 | ADVIA CENTAUR ANTI-HBS2 (AHBS2) ASSAY AND QAULITY CONTROL MATERIAL | SEI | 17 | October 17, 2025 | accessdata.fda.gov |
| October 11, 2011 | P090024 | ADVIA CENTAUR HBEAG ASSAY AND QUALITY CONTROL MATERIAL | LOM | 13 | October 17, 2025 | accessdata.fda.gov |
| May 26, 2005 | P030049 | ADVIA CENTAUR HBSAG READY PACK REAGENTS/CONFIRMATORY READY PACK REAGENTS/QUALITY CONTROL MATERIAL | LOM | 14 | March 11, 2021 | accessdata.fda.gov |
| March 7, 2005 | P040017 | ADVIA CENTAUR HAV TOTAL ASSAY, ADVIA CENTAUR HAV TOTAL QUALITY CONTROL MATERIALS | LOL | 0 | March 7, 2005 | accessdata.fda.gov |
| December 22, 2004 | P040018 | ADVIA CENTAUR HAV IGM READY PACK REAGENTS, ADVIA CENTAUR HAV IGM QUALITY CONTROL MATERIALS | LOL | 0 | December 22, 2004 | accessdata.fda.gov |
| December 22, 2004 | P040004 | ADVIA CENTAUR HBC TOTAL READYPACK REAGENTS/ADVIA CENTAUR HBC TOTAL QUALITY CONTROL MATERIALS | SEI | 20 | March 29, 2022 | accessdata.fda.gov |
| December 22, 2004 | P030056 | ADVIA CENTAUR HCV READY PACK REAGENTS, ADVIA CENTAUR HCV QUALITY CONTROL MATERIALS | MZO | 18 | April 27, 2021 | accessdata.fda.gov |
| August 6, 2004 | P030040 | ADVIA CENTAUR HBC IGM READYPACK REAGENTS, ADVIA CENTAUR HBC IGM QUALITY CONTROL MATERIALS | SEI | 23 | October 17, 2025 | accessdata.fda.gov |
| September 8, 2000 | P990055 | BAYER IMMUNO 1 COMPLEXED PSA ASSAY | NAF | 28 | July 16, 2025 | accessdata.fda.gov |
| December 22, 1995 | P950021 | ADVIA CENTAUR & ADVIA CENTAUR CP PSA IMMUNOASSAY | MTG | 29 | July 16, 2025 | accessdata.fda.gov |
| September 29, 1995 | P930036 | ADVIA CENTAUR AFP REAGENTS AND CALIBRATORS | LOK | 25 | May 11, 2026 | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| July 13, 2026 | 99446 | Class II | Ongoing | Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mL | Due to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment, including potential life-threatening cardiac arrhythmias or inadequate antimalarial therapy. | accessdata.fda.gov |
| June 26, 2026 | 99381 | Class III | Ongoing | Syva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219UL | out-of-specification sodium azide concentration in Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls Lot U2. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is low, as exposure is limited by small volumes and a 0.2% post-reconstitution sodium azide concentration, with the worst outcome be | accessdata.fda.gov |
| October 6, 2025 | 97819 | Class II | Ongoing | IMMULITE 2000 Oak Mix Specific Allergen; Siemens Material Number (SMN): 10386105; Catalog Number: L2KUN6 | The barcode orientation on affected devices causes incorrect scanning order of tubes within the allergen holder wedge. When using an IMMULITE 2000 / IMMULITE 2000 XPi instrument in combination with a Zebra barcode scanner, the instrument will not correctly recognize the position of tubes within the allergen holder wedge. | accessdata.fda.gov |
| September 22, 2025 | 97672 | Class II | Ongoing | Assay: IMMULITE 2000 Intact PTH; Test Code: iPT; Siemens Material Number (SMN): (1) 10381441, (2) 10381442; Catalog Number: (1) L2KPP2, (2) L2KPP6 | The potential for falsely depressed Intact PTH patient results at the low end of the assay range, less than or equal to 50 pg/mL (less than or equal to 5.3 pmol/L), when using specific lots identified by the firm on the IMMULITE 2000/IMMULITE 2000 XPi systems. The bias is observed in both serum and plasma samples. | accessdata.fda.gov |
| April 15, 2025 | 96693 | Class II | Ongoing | Atellica IM Homocysteine Calibrator (2 Pack). Siemens Material Number: 10995498 | Certain lots of Atellica IM Homocysteine Calibrator and ADVIA Centaur HCY Calibrator do not meet the assay Instructions for Use (IFU) reference interval due to calibrator instability resulting in increased positive bias. | accessdata.fda.gov |
| November 22, 2024 | 95809 | Class II | Ongoing | epoc NXS Host; Siemens Material Number (SMN): 11413475 (US); Software Version Number: 4.14.9. Intended for use by trained medical professionals as an in vitro diagnostic device for the quantitative testing of samples of | Siemens Healthcare Diagnostics is recalling their epoc Blood Analysis System because of a software malfunction that occurs when specific criteria are met that can result in the incorrect patient name being assigned to a blood measurement by the device if the user of the device does not ensure verification of the correct patient name. The software malfunction | accessdata.fda.gov |
| September 30, 2024 | 95513 | Class II | Ongoing | IMMULITE 2000 PSA assay, Catalog Number L2KPTS2(D) (SMN 10706281) and Catalog Number L2KPTS6(D) (SMN 10706282) | The IMMULITE 2000 PSA assay for use on the IMMULITE 2000 and IMMULITE 2000 XPi analyzers did not meet the High-dose Hook Effect claim as stated in the Instructions for Use (IFU). | accessdata.fda.gov |
| July 26, 2024 | 95118 | Class II | Ongoing | Atellica IM CA 19-9 (50 Test)-In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum using the Atellica CI and Atellica IM Analyzers SMN: 10995490 | Positive bias for some samples around the CA 19-9 upper limit of normal of 35 U/m as compared to the previous lot. The sample bias observed was greatest in the Asia Pacific sample population. The observed bias is not proportional across the assay measuring interval and is less pronounced for sample results above a concentration of 110 U/mL. | accessdata.fda.gov |
| April 23, 2024 | 94495 | Class II | Ongoing | IMMULITE 2000 Anti-TG Ab Catalog # L2KTG2 (200 Tests), SMN 10381659, System, Test, Thyroid Autoantibody. | The potential for falsely elevated patient sample results when using impacted lots (782, 783, 785, 786, 787, 788, 789, 790, 791, 792 and 793), of IMMULITE 2000 Anti-TG Ab. | accessdata.fda.gov |
| January 9, 2023 | 91522 | Class II | Ongoing | Atellica IM Folate 140 test kit- For in vitro diagnostic use in the quantitative determination of folate in human serum and red blood cells. Siemens Material Number (SMN): 10995572 | Negative bias occurred when whole blood calibration (Atellica IM Fol or ADVIA Centaur FolateBA/FolBA) used to test serum samples. | accessdata.fda.gov |
| December 22, 2022 | 91552 | Class II | Ongoing | ADVIA Centaur XP and ADVIA Centaur XPT Anti-HBe2 (aHBe2) 50T- In vitro diagnostic immunoassay for the qualitative detection of antibodies to the e antigen of the hepatitis B virus (HBV) in human pediatric (2-21 years old | Anti-HBe2 (aHBe2) interference with the Hepatitis B e Antigen (HBeAg) Assay, leads to elevated or reactive Hepatitis B e Antigen (HBeAg) results on samples that are non-reactive when HBeAg testing follows aHBe2 testing, regardless of whether both tests are performed on the same sample | accessdata.fda.gov |
| November 4, 2022 | 91164 | Class II | Ongoing | IMMULITE 2000 Systems 3gAllergy Specific IgE Universal Kit Tests (600T)- US. Siemens Material Number (SMN): 10708840 For in vitro diagnostic use with the IMMULITE 2000 Systems Analyzers for the quantitative measurement o | Potential for falsely elevated specific IgE mold allergen reactivity with quality control material and patient samples, may result in false reactive result | accessdata.fda.gov |
| October 25, 2022 | 91108 | Class II | Ongoing | IMMULITE and IMMULITE 1000 Total Testosterone Assay- In vitro diagnostic use with the IMMULITE and IMMULITE 1000 Analyzers for the quantitative measurement of total testosterone in serum and heparinized plasma. | Confirmed an average positive bias of 40% for testosterone concentrations of approximately 660 ng/dL (22.9 nmol/L) and above with the IMMULITE/IMMULITE 1000 Total Testosterone Assay when compared to the IMMULITE 2000/IMMULITE 2000 XPi Total Testosterone Assay. Two (2) lots of Total Testosterone assays for the IMMULITE/IMMULITE 1000, kit lots #515 and #516 we | accessdata.fda.gov |
| August 11, 2022 | 90812 | Class II | Ongoing | IMMULITE 2000 and IMMULITE 2000 XPi Thyroid Stimulating Immunoglobulins (TSI) Siemens Material Number (SMN): 10876421 US; 10713448 (OUS) | An average negative bias of -23% with IMMULITE 2000/IMMULITE 2000 XPi Thyroid Stimulating Immunoglobulins (TSI) when compared to other in-date kit lots, there is a potential for erroneously depressed patient results. This may lead to a delayed follow up of patients with clinical autoimmune thyroid | accessdata.fda.gov |
| March 3, 2022 | 89953 | Class II | Ongoing | Atellica IM Enhanced Estradiol (eE2) 100T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10995561 All lots | Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results | accessdata.fda.gov |
| September 28, 2021 | 88792 | Class II | Ongoing | Atellica IM 1300 Analyzer, SMN 11066001 | Ancillary reagent packs used on Atellica IM 1300 and Atellica IM 1600 analyzers may overflow when pierced while on an analyzer located at an altitude of greater than 350m (1148ft) above sea level. As a result, customers at these altitudes may observe an increased number of Reagent Volume Check Errors. | accessdata.fda.gov |
| September 22, 2021 | 88768 | Class II | Terminated | Atellica IM SARS-CoV-2 Antigen Assay (100 Test Kit), SMN # 11207861 | Data provided in the Emergency Use Authorization (EUA) submission was insufficient to determine that the assays were adequately validated for the intended use. | accessdata.fda.gov |
| July 6, 2021 | 88431 | Class II | Ongoing | Atellica IM BR 27.29 (BR) Assay 50 Test Kit- in vitro diagnostic use in the quantitative serial determination of cancer antigen CA 27.29 in human serum and plasma (EDTA) using the Atellica IM Analyzer. SMN: 10995478 | Product does not meet the Instructions for Use (IFU) claimed Pack Calibration Interval of 10 days. IFU calibration updated interval from 10 days to 3 days for all current and future kit lot numbers | accessdata.fda.gov |
| April 21, 2021 | 87770 | Class II | Ongoing | Centaur Syphilis Assay-SYP Kit, 200 Test - Product Usage: For in vitro diagnostic use in the qualitative determination of antibodies to Treponema pallidum in human serum or plasma using the ADVIA Centaur XP/XPT System an | Potential for the ADVIA Centaur Syphilis assay to carryover into other commercial assays. This carryover effect only occurs when the impacted assays are used immediately following testing with the Syphilis assay on the ADVIA Centaur XP/XPT or ADVIA Centaur CP systems | accessdata.fda.gov |
| February 8, 2021 | 87381 | Class II | Terminated | Enzyme linked immunosorbent assay, for herpes simplex virus, hsv-2 | Potential false positive HSV results. Siemens Healthcare Diagnostics, Inc. initiated a correction for ADVIA Centaur4P Herpes-2 lgG (HSV2) Onboard Stability and Calibration Frequency (Interval) Failures on the ADVIA Centaur XP System and ADVIA Centaur XPT System. | accessdata.fda.gov |
| August 25, 2020 | 86383 | Class II | Terminated | Atellica IM HER-2/neu (H2n) assay, 50 Test Kit, Catalog No. SMN 10995591, UDI Codes: (01)00630414599151(10)98034139(17)20210130 and (01)00630414599151(10)32478139(17)20210130 Atellica IM HER-2/neu (H2n) calibrator, 2 Pac | Siemens confirmed that the Upper Limit of Normal (ULN) as claimed in the Instructions for Use (IFU) was no longer achieved. This can potentially result in false positive or false negative results. | accessdata.fda.gov |
| August 14, 2019 | 83653 | Class II | Terminated | Atellica IM anti-CCP IgG (aCCP) Assay Siemens Material Number: 10732998 (100 Test) Test Version1.0 - Product Usage: The ADVIA Centaur Anti-CCP IgG (aCCP) assay is for in vitro diagnostic use in the semi-quantitative dete | Atellica IM anti-CCP IgG (aCCP) Test Definition (TDef) Mitigation Failure-reagent carryover mitigation for the Testosterone II (TSTII) assay is unable to be completed as defined in the aCCP Test Definition (TDef). The issue occurs on an Atellica IM Analyzer and is isolated to TDef Version 1.0. FOR OUS: Atellica IM anti-CCP IgG (aCCP) and Pregnancy-Associated | accessdata.fda.gov |
| July 22, 2019 | 84078 | Class II | Terminated | Siemens ADVIA Centaur Folate 100 test kit-for IVD of folate in serum or red blood cells SMN:10310308 | Homocysteine Assay May Cause Elevated Results in the Folate Assay | accessdata.fda.gov |
| December 7, 2018 | 82521 | Class II | Terminated | Siemens ADVIA Centaur aTG (100 test kit) Siemens Material Number (SMN): 10492398 | Positive bias anti-thyroglobulin with ADVIA Centaur aTG kit lots ending in 316 and lower and Atellica IM aTG kit lots ending in 317 and lower when compared to the standardization to World Health Organization (WHO) Reference Preparation MRC 65/93 stated in the Instructions for Use (IFU). | accessdata.fda.gov |
| July 24, 2018 | 80954 | Class II | Terminated | ADVIA Centaur CKMB Calibrator, Cat No. 09318028 Product Usage: For in vitro diagnostic use in calibrating ADVIA Centaur systems CKMB assays. | A potential bias was identified with certain kits compared to the internal standards. | accessdata.fda.gov |
| February 21, 2018 | 79678 | Class II | Terminated | ADVIA Centaur CA 125II Assay; Cat No. 09427226, SMN 10310443 (1-pack/100 tests); Cat no. 01678114, SMN 10315696 (5-pack/500 tests) | Upon dilution, some patient samples may exhibit over-recovery outside the representative data provided in the assay instructions for use. | accessdata.fda.gov |
| July 28, 2017 | 79170 | Class II | Terminated | ADVIA Centaur T3 ADVIA Centaur T3: For in vitro diagnostic use in the quantitative determination of triiodothyronine (T3) in serum using the ADVIA Centaur, ADVIA Centaur XP, and ADVIA Centaur XPT systems. Measurements of | Siemens has identified an issue when scanning the 20 barcode for the Master Curve Card (MCC) with ADVIA Centaur systems T3 kit lots ending in 198 on the ADVIA Centaur XPT system. | accessdata.fda.gov |
| June 7, 2017 | 78645 | Class II | Terminated | ADVIA Centaur Calibrator 30, 2 pack, 6 pack, and Ref 2 pack. Siemens Material Number (SMN): 10379810, 10379811, 10697756. | Siemens Healthcare Diagnostics has confirmed a negative bias for ADVIA Centaur Enhanced Estradiol (eE2) on the ADVIA Centaur, ADVIA Centaur XP and ADVIA Centaur XPT systems when calibrating with Calibrator 30 kit lots ending in 21 (C3021) as compared to Calibrator 30 kit lots ending in 20 (C3020). | accessdata.fda.gov |
| April 5, 2017 | 76992 | Class II | Terminated | ADVIA Centaur Systems Insulin Calibrator; Test Code: Calibrator IRI; Catalog Number: 04618899 | Current lots of ADVIA Centaur/XP/XPT/CP Insulin (IRI) assay recover approximately 40% higher than the World Health Organization (WHO) 1st IRP 66/304 standardization based on slope values. Other performance characteristics are being met per the assay Instructions for Use. Overall risk to health is negligible and Siemens is not recommending a review of previou | accessdata.fda.gov |
| March 8, 2017 | 76766 | Class II | Terminated | Siemens ADVIA Centaur BR assay Cat No. 02419937, SMN 10333349 (1-pack/50 tests) BR Assay for CA 27.29 The ADVIA Centaur BR assay is an in vitro diagnostic test for the quantitative serial determination of cancer antigen | Potential for the ADVIA Centaur Syphilis assay to interfere with the BR (CA 27.29) a assay on the ADVIA Centaur Systems | accessdata.fda.gov |
| January 10, 2017 | 76285 | Class II | Terminated | Siemens ADVIA Centaur Systems Calibrator A Kits, Cat No. 04800646, SMN 10285903 (2 pack)Cat No. 04800735, SMN 10285904 (6 pack) Cat No. 04800840, SMN 10285905 (6 pack - REF) | Siemens Healthcare Diagnostics has confirmed a negative bias for ADVIA Centaur FT4 when used with Calibrator A kit lots ending in 90 on the ADVIA Centaur, ADVIA Centaur XP and ADVIA Centaur XPT Systems. In addition, Siemens Healthcare Diagnostics confirmed the potential for calibration failures due to above limit calibrator RLU %CVs when using Calibrator A k | accessdata.fda.gov |
| January 4, 2017 | 76212 | Class II | Terminated | ADVIA Centaur Progesterone; Catalog Number: 10310305 10315522 10333111 Product Usage: The PROG method is an in vitro diagnostic test for the quantitative measurement of progesterone in human serum and plasma on the Dimen | DHEA-S causes falsely elevated progesterone results. | accessdata.fda.gov |
| October 19, 2016 | 75523 | Class II | Terminated | ADVIA Centaur CA 19-9 Assay (50 test kit)-for use, with the ADVIA Centaur and ADVIA Centaur XP, ADVIA Centaur XPT and ADVIA Centaur CP systems. Siemens Material Number(SMN): 10491379 In the 510(k) database the CA 19-9 as | CA 19-9 assay on the ADVIA Centaur CP does not meet the correlation to the CA 19-9 assay on the ADVIA Centaur/XP/XPT systems as stated in the Instructions for Use. | accessdata.fda.gov |
| October 5, 2016 | 75394 | Class II | Terminated | Siemens ADVIA Centaur Vitamin D Total Assay SMN 10699201 (100 test) | Vitamin D Total- Change in Correlation Between Serum and Plasma Specimen Tubes- negative bias with plasma vs. serum samples | accessdata.fda.gov |
| August 9, 2016 | 74917 | Class II | Terminated | ADVIA Centaur PSA Assay; Cat No. 06574155/SMN 10310292 (100 test)/02676506/SMN 10310293 (500 test) | Communication provided to emphasize that the PSA values should be interpreted in accordance with current clinical guidelines for defining biochemical recurrence following radical prostatectomy. | accessdata.fda.gov |
| August 8, 2016 | 74951 | Class II | Terminated | Siemens ADVIA Centaur Calibrator U, For in vitro diagnostic use in calibrating the following assays using ADVIA Centaur"' systems: Myoglobin cTnl Cat No. ADVIA Centaur Calibrator U (2 Pack) - 03684480 (SMN 1 0309996) | Failure of analytical sensitivity with Calibrator U kit lots ending in 63 and 64 and a drift from the internal standardization | accessdata.fda.gov |
| May 2, 2016 | 74036 | Class II | Terminated | Siemens Healthcare ADVIA Centaur Tnl-Ultra Assay. In-Vitro Diagnostic for quantitative determination of cardiac troponin For in vitro diagnostic use in the quantitative determination of cardiac troponin I (cTnl) in serum | Exhibits a greater than 10% change in results in samples with biotin levels up to 10 ng/mL (41 nmol/L). Instructions for Use (IFU) states that specimens that have up to 10 ng/mL (41 nmol/L) of biotin | accessdata.fda.gov |
| February 4, 2016 | 73263 | Class II | Terminated | Siemens Healthcare Diagnostics ADVIA Centaur Calibrator E - 2-Pack Catalog Number: 04634452 SMN: 10309079 ADVIA Centaur Calibrator E For in vitro diagnostic use in calibration the following assays using ADVIA Centaur sys | ADVIA Centaur Systems Calibrator E Lot 42 and 43 Bias with the Testosterone Assay | accessdata.fda.gov |
| January 13, 2016 | 73052 | Class II | Terminated | Siemens ADVIA Centaur Enhance Estradiol Test Code eE2 Catalog Number: 10490889, 10491445, 10697757 Product Usage: For in vitro diagnostic use in the quantitative determination of estradiol in human serum and plasma (hepa | The drug fulvestrant (Faslodex) may cause falsely elevated estradiol results. | accessdata.fda.gov |
| December 29, 2015 | 72968 | Class II | Terminated | ADVIA Centaur PSA Assay; Catalog Number: 06574155/SMN 10310292 (100 test kit) and Catalog Number: 02676506/SMN 10310293 (500 test kit) Product Usage: This in vitro diagnostic assay is intended to quantitatively measure p | PSA assay is not meeting the High Dose Hook Effect expectation in the Instructions for Use (IFU). | accessdata.fda.gov |
| July 27, 2015 | 71843 | Class II | Terminated | ADVIA Centaur Folate Ascorbic Acid/Ascorbic Acid Diluent; SMN 10316877. Used to prepare the Red Blood Cell hemolysate for use with the ADVIA Centaur systems folate assay. | Low red blood cell control recoveries and low results for red blood cell patient samples when using the ADVIA Centaur Systems Folate assay. | accessdata.fda.gov |
| May 19, 2015 | 71337 | Class II | Terminated | ADVIA Centaur Tni-Ultra Assay; SMN 10317708 - 100 tests and SMN 10317709 -500 tests Product Usage: For in vitro diagnostic use in the quantitative determination of cardiac troponin I (cTnl) in serum, heparinized plasma, | System-to-system bias between the Tni-Ultra assay on the ADVIA Centaur CP and ADVIA Centaur/ADVIA Centaur XP/ADVIA Centaur XPT systems. | accessdata.fda.gov |
| May 6, 2015 | 71073 | Class II | Terminated | The Rapidlab 1260 system is a blood gas analyzer used for laboratory testing of blood gases, electrolytes, metabolites and CO-oximetry in arterial, venous and capillary whole blood samples. | D50 and D51 Diagnostic error codes are not functional. | accessdata.fda.gov |
| January 27, 2015 | 70470 | Class II | Terminated | ADVIA Centaur Systems Progesterone Kit, (1 -pack) In Vitro Diagnostic; Catalog number: 02382928; SMN: 10310305. | ADVIA Centaur Systems Progesterone Kit Lots Ending in 268 have a high bias on results greater than 30 ng/mL (95.4 nmol/L) | accessdata.fda.gov |
| October 6, 2014 | 69461 | Class III | Terminated | ADVIA Centaur BNP Assay for in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur, Centaur XP, Centaur CP Systems; Catalog Numbers: Cat No. | Siemens Healthcare Diagnostics has confirmed that approximately 2000 ReadyPacks from the ADVIA Centaur Systems BNP reagent contains an ADVIA Centaur Systems FT4 human-readable side label. | accessdata.fda.gov |
| September 26, 2014 | 69430 | Class II | Terminated | Siemens Calibrator E; SMN 10309079 (2 pack), SMN 10321075 (6 pack), SMN 10335532 (6 pack Ref) | Positive bias for Calibrator E lot kits ending in 38 and 39 with the ADVIA Centaur Systems Cortisol and Progesterone assays compared to the respective master curves. | accessdata.fda.gov |
| September 19, 2014 | 69228 | Class II | Terminated | External power supply adaptors that accompany Clinitek Status+ The Clinitek Status systems is a urine analyzer. | The external power supply for the Clintek Status analyzer, which is provided separately, is damaged. It can result in an electric shock to the User. | accessdata.fda.gov |
| September 15, 2014 | 69292 | Class II | Terminated | Siemens ADVIA Centaur Systems HBc Total (HBcT), Reagent. For In Vitro Diagnostic Use Catalog Number: 07566733 Siemens Material Number: 10309508 The ADVIA Centaur HBc Total assay is an in vitro diagnostic test for the qua | Increased imprecision and positive bias is observed with patient samples and negative controls and can result in an increase in initial reactive results. | accessdata.fda.gov |
| September 12, 2014 | 69282 | Class III | Terminated | ADVIA Centaur and ADVIA Centaur XP and ADVIA Centaur CP Cleaning Solution (For in vitro diagnostic use with the ADVIA Centaur systems) Catalog Number: 112748 (Siemens Material Number (SMN): 10310041 The Cleaning Solution | Stability of the ADVIA Centaur Cleaning Solution is not assured | accessdata.fda.gov |
| June 23, 2014 | 68665 | Class II | Terminated | SIEMENS ADVIA Centaur CP Immunoassay System BNP kit; SMN 10309044 - 100 test For in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur CP Sy | Complaints of failed calibration. | accessdata.fda.gov |
| June 2, 2014 | 68537 | Class II | Terminated | Siemens Healthcare ADVIA Acid/Base Reagent 1 and 2 Kit containing ADVIA Centaur Acid Reagent bottles, lot number: 454778 Kit Catalog Number: 112219 SMN: 10310026 Intended Use: In vitro diagnostic use. Acid Regent is a co | Swollen acid bottles due to a trace metal contamination in the Acid Reagent bottles | accessdata.fda.gov |
| May 30, 2014 | 68520 | Class II | Terminated | ADVIA Centaur Systems TnI-Ultra assay; Catalog Number 02789602 (100 tests), SMN 10317708 and 02790309 (500 tests), SMN 10317790 | The solid phase reagent in some of the ADVIA Centaur TnI -Ultra ReadyPacks, lot 084, is darker in appearance, creating a potential for incorrect control and patient results. | accessdata.fda.gov |
| April 10, 2014 | 67953 | Class II | Terminated | ADVIA Centaur Systems TSH3 Ultra Ready Pack, 100 test Catalog Number: 06491072; Siemens Material Number: 10282378. Intended for the invitro diagnostic use in quantitative determination of various assays on the ADVIA Cent | Samples containing fluorescein may show interference with the ADVIA Centaur Systems TSH3 Ultra, Vitamin D and the ADVIA Centaur BRAHMS Procalcitonin assays. | accessdata.fda.gov |
| March 25, 2014 | 67839 | Class II | Terminated | Siemens ADVIA Centaur Folate Cat No. 06891541 SMN 10325366 (500 tests) Cat No. 06367974 SMN 10310308 (100 tests) Cat No. 00203473 SMN 10331250 (Ref) (500 tests) Cat No. 09132781 SMN 10340209 (Ref) (2500 tests) For in vit | Serum controls may go out of range low with the ADVIA Centaur Systems Folate assay and a shift in whole blood patient may result with kit lots ending in 219 and 223 | accessdata.fda.gov |
| December 18, 2013 | 67021 | Class II | Terminated | ADVIA Centaur Systems Phenytoin Calibrator N ( PHTN) 2-pack SMN 10311391 For in vitro diagnostic use in the quantitative determination of phenytoin in serum or plasma using the ADVIA Centaur and ADVIA Centaur XP systems | ADVIA Centaur Systems Phenytoin Calibrator N, lots CN58 and higher, change in recovery observed with the ADVIA Centaur Systems Phenytoin assay compared to recoveries using previous Calibrator N lots. | accessdata.fda.gov |
| August 16, 2013 | 66132 | Class III | Terminated | ADVIA Centaur Intact PTH Calibrator (6 pack); Catalog Number: SMN 10492387 For in vitro diagnostic use in calibrating Intact PTH assays on the ADVIA Centaur Systems. | PTH Calibrator packaged with only high calibrator. | accessdata.fda.gov |
| July 25, 2013 | 65806 | Class II | Terminated | ADVIA Centaur Folate (100 Tests), SMN 10310308, Cat No. 06367974 In vitro diagnostic use in the quantitative determination of folate in serum or red blood cells. | Calibration failures and/or significant negative shifts in quality control (QC) and patient results. | accessdata.fda.gov |
| June 28, 2013 | 65626 | Class III | Terminated | ADVIA Centaur Calibrator A. Cat. #04800735, SMN 10285904 (6 pack); Cat. # 04800840, SMN 10285905 (6 pack - REF). For calibrating the following assays using the ADVIA Centaur or ACS:180 systems: FT3, T3, T4, Tup, FT4, THE | Calibrator A lot CA77 is under-recovering to the assigned target for the ADVIA Centaur Total T4 Assay. | accessdata.fda.gov |
| June 25, 2013 | 65562 | Class II | Terminated | ADVIA Centaur HCY Diluent - 10mL Bottle Catalog number 09877493 (124533), SMN 10310370, and Ancillary Pack Catalog number 03302138 (124581), SMN 10378677. Used on the ADVIA Centaur, ADVIA Centaur XP and ADVIA Centaur CP | ADVIA Centaur Homocysteine dilution recovery on the diluent identified the percent recovery for the 1:10 patient sample dilutions lower than reported in the Instructions for Use (IFU). | accessdata.fda.gov |
| May 14, 2013 | 65224 | Class II | Terminated | ADVIA Centaur iPTH ReadyPack Assay 100 Tests; REF 10492368. For in vitro diagnostic use in the quantitative determination of intact parathyroid hormone (iPTH). | iPTH Assay- reagent and calibrator lots may have demonstrated higher than anticipated variability | accessdata.fda.gov |
| May 10, 2013 | 65162 | Class II | Terminated | ADVIA Centaur Systems TSH3 Ultra ReadyPack ((REF 06491072 - 100 Tests, REF 06491080 - 500 Tests, REF 04862625 - 2500T). Intended to quantitatively measure human thyroid stimulating hormone (TSH, thyrotropin). | A rare variant of TSH, identified in a small cluster of patients, is not detected. | accessdata.fda.gov |
| March 13, 2013 | 64610 | Class II | Terminated | ADVIA Centaur Vitamin D Assay (100 tests); Reference Number: 10491994. For use in the quantitative determination of Vit D. | Negative bias in patient samples for Vitamin D | accessdata.fda.gov |
| November 14, 2012 | 63682 | Class II | Terminated | Siemens Healthcare BNP (8-type Natriuretic Peptide) 500 Test kit 02816634 100 Test 02816138 10309045, 10309044 028 Intended Use For in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide | Operating range of the ADVIA Centaur systems is 18C to 30C (64.4F to 86.0F), a change in room temperature may increase or decrease assay results, depending on the specific assay and ADVIA Centaur system used. | accessdata.fda.gov |
| October 9, 2012 | 69449 | Class II | Terminated | ADVIA Centaur Ferritin Calibrator C-Used with the ADVIA Centaur Ferritin assay on the ADVIA Centaur CP system only. (In-Vitro Diagnostic) Catalog Number: 03439230 (2 pack) | Ferritin Analytical Sensitivity and Calibrator C Realignment with kit lots ending in 22 and 23 used with the ADVIA Centaur Ferritin assay on the ADVIA Centaur CP system | accessdata.fda.gov |
| September 11, 2012 | 63167 | Class II | Terminated | Siemens ADVIA Centaur BR Assay: Catalog Number: US: REF 02419937 (10214722) (50 Tests); REF 03896216(10334837)(250 Tests) Not CE Marked; OUS: REF03204829(10310271)(50 Tests); REF 01157807(1 0314722) (250 Tests) CE Marked | BR Assay for CA 27.29 Calibration Interval Change due quality control (QC) results outside of the expected ranges. | accessdata.fda.gov |
| August 7, 2012 | 62897 | Class III | Terminated | ADVIA Centaur Prolactin Assay: ADVIA Centaur Calibrator B Catalog Number. Prolactin:110757 and 110758: US:Calibrator B 00652707 (6 pack) or 00649625 (2 pack ) OUS: 2 pack REF: 00650577 and Ref: 00654130 (6 pack) Product | ADVIA Centaur Prolactin Assay and FSH, Calibrator B fails the analytical sensitivity stated in the IFU for lots below 40 | accessdata.fda.gov |
| July 25, 2012 | 62702 | Class II | Terminated | Siemens ADVIA Centaur Multi-Diluent 1 - Used for automated dilutions for the ADVIA Centaur BNP and TSH3 Ultra assays when on-board the ADVIA Centaur or ADVIA Centaur XP systems. Catalog Numbers: 2 Pack REF 07907174 (1103 | Decrease in onboard dilution recovery when using Multi-Diluent 1 that has been stored on board the ADVIA Centaur and ADVIA Centaur XP systems for for BNP and TSH3 Ultra assays | accessdata.fda.gov |
| July 17, 2012 | 62640 | Class II | Terminated | Siemens ADVIA Centaur Syphilis (SYPH) Assay, 200 ReadyPack Reference Number 10492493 Product Usage: The ADVIA Centaur Syphilis (SYPH) assay is an in vitro diagnostic immunoassay for the qualitative determination of antib | Syphilis Assay Interference with HBsAg Assay | accessdata.fda.gov |
| March 6, 2012 | 61393 | Not yet classified | Terminated | Siemens ADVIA Centaur Cortisol Assay Cat. Nos. 04610138 (1 0321 026)- 250 Test kit 04610049(10309078)- 50 Test kit 04611509 (1 0335503)- 250 REF Test kit ADVIA Centaur Systems Cortisol: For in vitro diagnostic use in the | Cortisol Assay reagent kit lots do not meet onboard stability and calibration interval claims | accessdata.fda.gov |
| February 16, 2012 | 61236 | Not yet classified | Terminated | Siemens ADVIA Centaur Vitamin D Diluent 2-pack, Reference 10494100 in vitro diagnostic use in the quantitative determination of total 25 (OH) vitamin D in human serum and plasma (EDTA, lithium-heparin, sodium heparin) us | Automatic and system-performed dilution calculation factor for Vitamin D dilutions is incorrect and causes diluted patient samples to under recover by approximately 50%. | accessdata.fda.gov |
| November 11, 2011 | 60502 | Not yet classified | Terminated | ADVIA Centaur CA19-9 Assay Cat. Nos. 123521 (03481938) - 250 Test kit w/o Calibrators 123519 (04612750) - 50 Test kit w/o Calibrators 10491244 - 250 Test kit w/Calibrators 10491379 - 50 Test kit w/Calibrators The ADVIA C | Positive bias of 14% and higher for some individual points for CA 19-9 results generated on the ADVIA Centaur CP system when they are compared to CA 19-9 assay results generated on either the ADVIA Centaur or ADVIA Centaur XP systems | accessdata.fda.gov |
| December 14, 2010 | 57427 | Not yet classified | Terminated | ADVIA Centaur CA 125 II Assay packaged in 100 and 500 test kits as follows: Product code: 09427226 (128532) 100 test kit Product code: 01678114 (128533) 500 Test kit | Positive bias (40-55%) with patient results greater than the upper limit of normal and less than the upper limit of normal | accessdata.fda.gov |
| October 3, 2008 | 60321 | Not yet classified | Terminated | ADVIA Centaur Intact PTH (iPTH) Assay -assay (lot 138) Cat. Nos. 100 Test kit 04385983 (129501) 500 Test kit 06587575 (129502). For in vitro diagnostic use in the quantitative determination of intact parathyroid hormone | Poor sensitivity and imprecision on ADVIA Centaur systems; Serum samples low bias; EDTA plasma samples low bias | accessdata.fda.gov |
| January 12, 2008 | 46346 | Not yet classified | Terminated | ADVIA Centaur HAV IgM, 100 Test Kit, used on the ADVIA Centaur or XP, REF: 05004126, in vitro diagnostic Hepatitis A test, Siemens Medical Solutions Diagnostics, Tarrytown, NY 10591. | Incorrect results: False reactive specimens on the ADVIA Centaur HAV IgM assay. | accessdata.fda.gov |
Compare with other makers
- All makers of Radioimmunoassay, Thyroid-Stimulating Hormone
- All makers of System, Test, Thyroid Autoantibody
- All makers of Single (Specified) Analyte Controls (Assayed And Unassayed)
- All makers of Immunochemical, Thyroglobulin Autoantibody
- All makers of System, Test, Immunological, Antigen, Tumor
- All makers of Radioassay, Triiodothyronine Uptake
Updated August 17, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.